SEC Form 4 · accession 0001209191-19-004607
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maria D Stahl
Officer — SVP and General Counsel
Period of report
Jan 17, 2019
Accepted (ET)
Jan 18, 2019 · 6:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 6, 2019 | A | 18,698 | — | A | 23,698 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Jan 17, 2019 | A | 40,000 | A | — | — | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitsF2,F4 | — | Jan 17, 2019 | A | 140,000 | A | — | — | Common Stock | 140,000 | 140,000 | D |
Explanation of responses
- F1On January 6, 2016, the Reporting person was granted 30,000 restricted stock units ("RSUs")( the "2016 RSU grant") that were previously reported on Table II Of Form 4, which form was filed with the Securities and Exchange Commission on January 8, 2016. Of the 2016 RSU grant, an aggregate of 30,000 shares have vested of which 11,302 shares were withheld by the Issuer to satisfy the reporting person's tax withholding obligations in connection with the delivery of the conversion of the RSUs into common stock on respective vesting dates. The total number of shares beneficially owned by the reporting person consists of the aggregate 18,698 RSUs converted into shares of common stock of the Issuer on the respective vesting dates and an additional 5,000 shares owned indirectly.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- F3These restricted stock units shall be eligible to vest upon achievement of certain performance conditions and, if such conditions are met, shall vest on various dates beginning no earlier than March 1, 2020 and ending no later than on March 1, 2022.
- F4The restricted stock units vest in three equal installments on each of January 17, 2020, January 17, 2021 and January 17, 2022.